- Home
- Publications
- Publication Search
- Publication Details
Title
Kinase dysfunction and kinase inhibitors
Authors
Keywords
-
Journal
VETERINARY DERMATOLOGY
Volume 24, Issue 1, Pages 181-e40
Publisher
Wiley
Online
2013-01-19
DOI
10.1111/j.1365-3164.2012.01081.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting the PI3K/Akt/mTOR Pathway – Beyond Rapalogs
- (2015) Oncotarget
- Acquired resistance to drugs targeting receptor tyrosine kinases
- (2011) Steven A. Rosenzweig BIOCHEMICAL PHARMACOLOGY
- Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab
- (2011) Toni M. Brand et al. CANCER BIOLOGY & THERAPY
- Mechanisms of Resistance to EGFR TKIs and Development of a New Generation of Drugs in Non-Small-Cell Lung Cancer
- (2011) Takayuki Kosaka et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Tyrosine kinase gene fusions in cancer: translating mechanisms into targeted therapies
- (2011) Sandrine Medves et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Anaplastic lymphoma kinase in human cancer
- (2011) Antonella Barreca et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: An Updated Systematic Review and Meta-analysis of Randomized Trials
- (2011) Liat Vidal et al. JNCI-Journal of the National Cancer Institute
- Multicenter Prospective Trial of Hypofractionated Radiation Treatment, Toceranib, and Prednisone for Measurable Canine Mast Cell Tumors
- (2011) K.S. Carlsten et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
- (2011) Alice T Shaw et al. LANCET ONCOLOGY
- Genetic and epigenetic changes in lung carcinoma and their clinical implications
- (2011) Jing Wen et al. MODERN PATHOLOGY
- Pushing the Envelope in the mTOR Pathway: The Second Generation of Inhibitors
- (2011) E. Vilar et al. MOLECULAR CANCER THERAPEUTICS
- Treatment of HER2-positive breast cancer: current status and future perspectives
- (2011) Carlos L. Arteaga et al. Nature Reviews Clinical Oncology
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential Properties of Current Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors
- (2011) George D. Demetri SEMINARS IN ONCOLOGY
- Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study
- (2011) E. Chon et al. Veterinary and Comparative Oncology
- Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study
- (2011) C. Robat et al. Veterinary and Comparative Oncology
- Preliminary evidence for biologic activity of toceranib phosphate (Palladia®) in solid tumours
- (2011) C. London et al. Veterinary and Comparative Oncology
- Imatinib elicited a favorable response in a dog with a mast cell tumor carrying a c-kit c.1523A>T mutation via suppression of constitutive KIT activation
- (2011) Osamu Yamada et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- The potential for crizotinib in non-small cell lung cancer: a perspective review
- (2011) Yung-Jue Bang Therapeutic Advances in Medical Oncology
- Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors
- (2010) Kevin A. Hahn et al. AMERICAN JOURNAL OF VETERINARY RESEARCH
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Front-line management of diffuse large B cell lymphoma
- (2010) Fernando Cabanillas CURRENT OPINION IN ONCOLOGY
- Treatment strategy for HER2-positive breast cancer
- (2010) Hirofumi Mukai International Journal of Clinical Oncology
- Status of PI3K inhibition and biomarker development in cancer therapeutics
- (2009) B. Markman et al. ANNALS OF ONCOLOGY
- Sunitinib
- (2009) Georgios S. Papaetis et al. BIODRUGS
- Mutations in the fifth immunoglobulin-like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours
- (2009) Mayu Isotani et al. BRITISH JOURNAL OF HAEMATOLOGY
- Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
- (2009) C. A. London et al. CLINICAL CANCER RESEARCH
- Effect of Tyrosine Kinase Inhibition by Imatinib Mesylate on Mast Cell Tumors in Dogs
- (2009) M. Isotani et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Clinicopathological Features and Outcome for Dogs with Mast Cell Tumors and Bone Marrow Involvement
- (2009) L. Marconato et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Masitinib is Safe and Effective for the Treatment of Canine Mast Cell Tumors
- (2009) K.A. Hahn et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Review: Predictive and prognostic markers for epidermal growth factor receptor inhibitor therapy in non-small cell lung cancer
- (2009) Nir Peled et al. Therapeutic Advances in Medical Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search